Pekin Hardy Strauss, Inc. Heron Therapeutics, Inc. Transaction History

Pekin Hardy Strauss, Inc.

$749 Million
Q3 2024

A detailed history of Pekin Hardy Strauss, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 15,170 shares of HRTX stock, worth $16,990. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,170

Previous 25,170 39.73%

Holding current value

$16,990

Previous $88,000 65.91%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.73 - $3.67 $17,300 - $36,700	-10,000 Reduced 39.73%	15,170 $30,000
Q2 2024 Aug 09, 2024	SELL	$2.32 - $3.86 $13,919 - $23,160	-6,000 Reduced 19.25%	25,170 $88,000
Q1 2024 May 02, 2024	SELL	$1.71 - $3.06 $9,063 - $16,218	-5,300 Reduced 14.53%	31,170 $86,000
Q4 2023 Feb 05, 2024	SELL	$0.54 - $1.82 $12,217 - $41,177	-22,625 Reduced 38.29%	36,470 $61,000
Q3 2023 Nov 07, 2023	SELL	$0.97 - $1.8 $45,638 - $84,690	-47,050 Reduced 44.33%	59,095 $60,000
Q2 2023 Aug 08, 2023	SELL	$1.11 - $2.88 $516,771 - $1.34 Million	-465,560 Reduced 81.43%	106,145 $123,000
Q1 2023 May 08, 2023	SELL	$1.51 - $3.25 $226 - $487	-150 Reduced 0.03%	571,705 $863,000
Q4 2022 Feb 13, 2023	SELL	$2.25 - $4.67 $160,335 - $332,784	-71,260 Reduced 11.08%	571,855 $1.43 Million
Q3 2022 Nov 09, 2022	BUY	$2.66 - $5.37 $6,051 - $12,216	2,275 Added 0.36%	643,115 $2.71 Million
Q2 2022 Aug 05, 2022	BUY	$2.3 - $6.29 $97,922 - $267,796	42,575 Added 7.12%	640,840 $1.79 Million
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $129,755 - $278,568	28,025 Added 4.91%	598,265 $3.42 Million
Q4 2021 Feb 08, 2022	BUY	$8.35 - $12.6 $1.06 Million - $1.6 Million	126,855 Added 28.61%	570,240 $5.21 Million
Q3 2021 Nov 12, 2021	SELL	$10.13 - $15.0 $3.38 Million - $5 Million	-333,315 Reduced 42.91%	443,385 $4.74 Million
Q2 2021 Aug 12, 2021	BUY	$13.27 - $18.48 $3.4 Million - $4.73 Million	255,895 Added 49.13%	776,700 $12.1 Million
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $787,792 - $1.13 Million	54,368 Added 11.66%	520,805 $8.44 Million
Q4 2020 Feb 11, 2021	SELL	$14.61 - $22.14 $1.88 Million - $2.84 Million	-128,476 Reduced 21.6%	466,437 $9.87 Million
Q3 2020 Nov 12, 2020	BUY	$13.67 - $17.77 $1,941 - $2,523	142 Added 0.02%	594,913 $8.82 Million
Q2 2020 Aug 10, 2020	BUY	$10.89 - $21.47 $65,764 - $129,657	6,039 Added 1.03%	594,771 $8.75 Million
Q1 2020 May 11, 2020	BUY	$10.23 - $24.56 $1.01 Million - $2.43 Million	98,772 Added 20.16%	588,732 $6.91 Million
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $8.54 Million - $13 Million	489,960 New	489,960 $11.5 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.

Account

Pekin Hardy Strauss, Inc. Heron Therapeutics, Inc. Transaction History